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Andre R SimonAbstract
Congenitally corrected transposition of the great arteries is a complex congenital cardiac anomaly with a wide
spectrum of morphologic features and clinical profiles. Most patients are diagnosed late in their life, undergoes
surgical repairs, eventually leading to systemic ventricular failure needing heart transplant or mechanical circulatory
assistance. As, aorta is located anterior to and left of the PA (Transposition of great arteries), the outflow graft of
ventricular assist device traverse across pulmonary artery to reach aorta which poses challenge during further
surgical explorations.
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deviceBackground
Congenitally corrected transposition of the great arteries
(CCTGA) is a complex congenital cardiac anomaly with
a wide spectrum of morphologic features and clinical
profiles. Most patients are diagnosed late in their life,
undergoes surgical repairs, eventually leading to sys-
temic ventricular failure needing heart transplant or
mechanical circulatory assistance. Normally, the outflow
graft of the ventricular assist device (VADs), especially
with new axial flow devices, ejects from the device and
navigates by the right side of the heart to terminate into
the ascending aorta. Due to the anatomical anomaly we
describe a modificated surgical technique for positioning
the ventricular assist device outflow graft.Case presentation
A 53 year old gentleman was diagnosed of congenitally
corrected transposition of great arteries (CCTGA) with
pulmonary stenosis in his thirties. He had DDD pace-
maker implanted at that time for atrio-ventricular block.
He was normally fit and active but had over the previous* Correspondence: drprashantis@rediffmail.com
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reproduction in any medium, provided the orsix months noticed a reduction in his effort capacity. His
heart failure therapy was intensified with beta-blocker,
ACE inhibitor and diuretics, despite he gradually dete-
riorated to NYHA class III. Echocardiography revealed
moderately dilated, hypertrophied systemic ventricle
with significant systolic impairment (Ejection Fraction of
14%). There was moderate tricuspid regurgitation. There
was incoordination of both ventricles. It was decided to
implant left ventricular assist device (LVAD) for signifi-
cant systemic ventricular dysfunction secondary to
CCTGA.
Chest was opened by sternotomy and patient was put
on cardiopulmonary bypass through an arterial cannula
in ascending aorta and two-stage venous cannula in
right atrium. Heartmate II teflon ring was attached to
the systemic ventricle using 16 pledgeted Polyester
(Ethibond Excel) 2–0 sutures. The myocardium within
the ring lumen was resected using coring knife and
Heartmate II inflow cannula was then inserted through
it. The outflow graft was anastomosed to ascending
aorta using side biting clamp with a 4–0 running Poly-
propylene suture and de-aired by releasing clamps be-
fore knotting. The LVAD was started as CPB weaned off
slowly to generate flows of 4 to 5 l/min. The post-
operative course was smooth and the patient wasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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heart transplantation.
A computed tomography (CT) of the thorax was done
in routine follow up after 6 months which showed the
outflow graft of LVAD passing over Pulmonary artery
(PA) under the upper sternum, transversing to the left
and anastomosing to the side of aorta (Figure 1). Recon-
struction of CT images showed the whole course of the
graft (Figure 2). The graft was passing from right to left
side under the upper sternum to reach the aorta which
is abnormally situated on the left side of the PA.
Discussion
Adults with congenital heart defects and congestive
heart failure are a challenging population because of
its complex anatomy, prior surgical palliation, and
hemodynamic status. Advances in palliation of con-
genital heart disease have resulted in improved survival
to adulthood. Many of these patients ultimately de-
velop end-stage heart failure requiring heart transplant
or LVAD implantation.
The CCTGA is characterized by atrio-ventricular and
ventriculo-arterial discordance in which morphologic
right ventricle functions as the systemic ventricle (SV),
whereas the morphologic left ventricle functions as the
pulmonary ventricle (PV). In this anomaly, the systemic
atrio-ventricular valve (SAVV) is a morphologic tricus-
pid valve, whereas the pulmonary atrio-ventricular valve
(PAVV) is a mitral valve [1,2]. The great arteries are
transposed, with the aorta rising from the RV and the
PA rising from the LV. The aorta is located anterior to
and left of the PA; thus, the prefix of ‘L’ is used [3]. Des-
pite adequate repair, patients with systemic RVs have an
increased risk for developing heart failure accompanied
by a high mortality rate [4].
At the time of referral for surgical repair, the majority of
these patients have significant SV dysfunction with advancedFigure 1 Contrast CT showing position of Outflow graft (OG) in
relation to pulmonary artery (PA) and aorta (Ao).symptoms. Although excellent early surgical results can be
achieved, residual impairment of the SV is common and
may eventually necessitate cardiac transplantation [5,6]. Sys-
temic ventricular failure is a known complication after a Sen-
ning or Mustard procedure because the morphologic RV
must function as the systemic ventricle [7].
Development in the field of mechanical circulatory as-
sist devices in recent decades offer an additional option
for patients of end stage heart disease with various
aetiologies including congenital heart disease [8]. If rapid
deterioration of cardiac function ensues before a donor
heart becomes available, the use of an LVAD may be the
only option for these patients. Implantation of an LVAD
in a patient with TGA after surgical repair was first
described by Wiklund et al., who achieved a successful
outcome using a HeartMate device [9]. Several cases of
VAD implantation using different generations of device
are reported in the literature [10,11].
Normally, the outflow graft of the VADs, especially with
new axial flow devices, ejects from the device and navi-
gates by the right side of the heart to terminate into the
ascending aorta. Both in TGA and CCTGA, the aorta is
located anterior to and left of the PA with various degrees
of malrotation. Hence, the outflow graft has to traverse
across the PA from right to left to reach the ascending
aorta. This brings the graft under the sternum in close
proximity. Reoperation is needed these cases for VAD ex-
plant, VAD up-gradation, pulmonary VAD implantation
or eventual heart transplant. Re-entry through the median
sternotomy is unavoidable under such circumstances. The
outflow graft lying under the sternum yields a great risk ofFigure 2 Reconstruction of CT images showing outflow graft
(OG) passing behind the sternum before anastomosing aorta
(Ao).
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haemorrhage and exsanguinations.
Different techniques of reinforcing and positioning the
outflow graft to make them less vulnerable at re-do ster-
notomy like tunnelling the graft in PTFE patch or
through the right pleural cavity were reported [12].
However, these techniques protect the graft in presence
of normal heart anatomy. In case of TGA due to anom-
alous relation of great arteries, the outflow graft crosses
midline over PA and comes in contact with sternum.
The injury at the time of re-do sternotomy can be
avoided by approximating the pericardium over the
graft, but there remains possibility of graft obstruction
due to pericardial tension. The thymic fat over the peri-
cardium can be mobilised and approximated over the
graft. Use of Gore-Tex, PTFE or Teflon sheet as a peri-
cardial substitute in cases of major cardiovascular oper-
ation to avoid injury during re-do sternotomy is well
reported [13]. Its use in LVAD surgery is not yet pub-
lished, although can be used in cases with graft coming
in contact with sternum. Another way to protect the
outflow graft is to tunnel it under superior vena cava be-
fore anastomosing over ascending aorta [14]. If none of
the techniques of graft protection were utilized at the
time of LAVD implantation, femoro-femoral cardiopul-
monary bypass and a careful dissection through right
second or third intercostal space before re-do sternot-
omy is essential.
Conclusion
Ventricular assist device implantation in patients with
congenitally corrected transposition of great arteries is a
technical challenge; however it can be performed in
experienced transplantation units with an acceptable
postoperative result.
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